The HVTN has accepted 17 scholars for the 2023-2024 RAMP Cohort 13 Scholar program! This is the largest cohort in program history, previous cohorts have ranged from 4 to 9 students. We have 14 scholars in the general program and 3 scholars in the alumni program.
The program criteria have expanded to include students who identify as Native American/American Indian, Native Hawaiian, Asian and Pacific Islander, and individuals granted deferred action for childhood arrivals (DACA) status by the U.S. Citizenship and Immigration Services.
The HIV Vaccine Trials Network, in collaboration with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, is investing in a young generation of HIV prevention researchers by providing them with opportunities to conduct independent research while receiving mentoring, project and salary funding, training, and professional development opportunities. Scholars will be working on their projects with sites in the US: Atlanta, Birmingham, and New York; Malawi: Lilongwe; South Africa: Cape Town and Soshanguve; and Zimbabwe: Harare.
To learn more about our scholars and the projects they will be working on, please visit the RAMP Scholar Profiles.
For more information, please visit www.hvtn.org/ramp or contact Linda Oseso, RAMP Program Manager, at email@example.com.